<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;General assessment. In: II guidelines for perioperative evaluation.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gualandro DM, Yu PC, Calderaro D, Marques AC, Pinho C, Caramelli B, et al. General assessment. In: II guidelines of perioperative evaluation. Arq Bras Cardiol. 2011;96(3 Suppl 1):4-7. [379 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Committee on Perioperative Evaluation (CAPO), Brazilian Society of Cardiology. General approach to the patient. In: I guidelines for perioperative evaluation. Arq Bras Cardiol 2007;89(6):e175-86.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Anemia, unspecified  (285.9); Chest pain, unspecified  (786.50); Complications affecting other specified body systems, not elsewhere classified, hypertension  (997.91); Electrocardiogram  (89.52); General physical examination  (89.7); Heart disease, unspecified  (429.9); Obesity, unspecified  (278.00); Pre-operative examination, unspecified  (V72.84); Unspecified diseases of blood and blood-forming organs  (289.9); Unspecified disorder of liver  (573.9)"/><FieldValue Value="MSH: Adrenal Cortex Hormones ; Anemia ; Antithyroid Agents ; Blood Cell Count ; Blood Chemical Analysis ; Blood Coagulation Disorders ; Blood Coagulation Tests ; Chest Pain ; Comorbidity ; Creatinine ; Diabetes Mellitus ; Diagnostic Tests, Routine ; Electrocardiography ; Fibrinolytic Agents ; Heart Diseases ; Hematologic Diseases ; Hematologic Tests ; Hypertension ; Intraoperative Complications ; Kidney Diseases ; Liver Diseases ; Medical History Taking ; Obesity ; Perioperative Care ; Physical Examination ; Postoperative Care ; Postoperative Complications ; Preoperative Care ; Respiratory Therapy ; Respiratory Tract Diseases ; Surgical Procedures, Operative ; Thyroid Hormones "/><FieldValue Value="MTH: Adrenal Cortex Hormones ; Anemia ; Antithyroid Agents ; blood cell count ; Blood Chemical Analysis ; Blood Coagulation Disorders ; Blood coagulation tests ; Chest Pain ; Creatinine ; Creatinine measurement, serum (procedure) ; Diabetes Mellitus ; Electrocardiography ; Fibrinolytic Agents ; Heart Diseases ; Hematologic Tests ; Hematological Disease ; Hypertensive disease ; Kidney Diseases ; Liver diseases ; Obesity ; Operative Surgical Procedures ; physical examination ; Plain chest X-ray ; Preoperative Procedure ; Respiratory Therapy ; Respiratory Tract Diseases "/><FieldValue Value="PDQ: anemia ; coagulation studies ; obesity ; perioperative/postoperative complications ; surgery "/><FieldValue Value="SNOMEDCT_US: Anemia  (271737000); Antithyroid agent  (418416001); Antithyroid agent  (5067008); Blood cell count  (88308000); Blood chemistry  (166312007); Blood coagulation disorder  (362970003); Blood coagulation disorder  (64779008); Blood coagulation panel  (3116009); Blood test  (252275004); Blood test  (396550006); Chest pain  (29857009); Complication of surgical procedure  (88797001); Corticoid preparation  (21568003); Corticoid preparation  (79440004); Creatinine  (15373003); Creatinine measurement, serum  (113075003); Diabetes mellitus  (73211009); Disease of blood AND/OR blood-forming organ  (191124002); Disease of blood AND/OR blood-forming organ  (34093004); Disease of liver  (235856003); Electrocardiographic procedure  (29303009); Heart disease  (56265001); Hypertensive disorder  (38341003); Inadequate preoperative assessment  (405367009); Kidney disease  (90708001); Obesity  (414915002); Obesity  (414916001); Perioperative care  (133897009); Physical assessment  (302199004); Physical assessment  (5880005); Physical assessment  (81375008); Plain chest X-ray  (399208008); Postoperative care  (133899007); Postoperative complication  (385486001); Preoperative care  (133898004); Preoperative procedures  (276028005); Respiratory therapy  (53950000); Surgical  (257556004); Surgical  (387713003); Surgical  (83578000); Thrombolytic  (303960004); Thrombolytic  (372742009); Thyroid hormone  (18220004)"/><FieldValue Value="UMD: Physiologic Monitor Modules, Electrocardiography  (20-771); Radiographic Systems  (18-429); Radiographic Systems, Digital, Chest  (18-431)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Any condition requiring surgery&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Risk Assessment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Anesthesiology" /><FieldValue Value="Cardiology" /><FieldValue Value="Colon and Rectal Surgery" /><FieldValue Value="Neurological Surgery" /><FieldValue Value="Orthopedic Surgery" /><FieldValue Value="Plastic Surgery" /><FieldValue Value="Surgery" /><FieldValue Value="Thoracic Surgery" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To refine and unify the terminology used by the entire multidisciplinary team, including the patients and their family &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To establish new routines, change indication for surgery according to the information obtained during the perioperative evaluation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To inform the patient and the team on the possible risks related to the intervention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To decrease perioperative complications &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Any patient who requires surgery&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xA;    &lt;li&gt;Patient history and physical examination&lt;/li&gt;&#xA;    &lt;li&gt;Electrocardiogram (ECG)&lt;/li&gt;&#xA;    &lt;li&gt;Chest x-ray&lt;/li&gt;&#xA;    &lt;li&gt;Laboratory tests (full blood count, hemostasis/coagulation tests, serum creatinine)&lt;/li&gt;&#xA;&lt;/ol&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Perioperative complications, morbidity and mortality &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cost-effectiveness &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The databases searched were PubMed, Scielo, and Lilacs. The guideline was updated, based on the last version of the guideline, and new evidence from 2007 to 2010 was obtained. There were no specific search terms. Articles published in Portuguese and English were included.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence in several populations from multiple randomized clinical trials or meta-analyses &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence in a limited group of populations from single randomized clinical trial or non-randomized clinical studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence in very limited group of populations from consensus and experts' opinions, case reports and series&lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Degree/Class of Recommendation - Reflecting the Size of Treatment Effect&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation I&lt;/strong&gt; - Benefit &amp;gt;&amp;gt;&amp;gt; Risk; the treatment/procedure must be indicated/administered&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa&lt;/strong&gt; - Benefit &amp;gt;&amp;gt; Risk; the choice for the treatment/procedure may help the patient&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIb&lt;/strong&gt; - Benefit &amp;gt; Risk; is not defined if the treatment/procedure can help the patient&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation III&lt;/strong&gt; - Risk &amp;gt; Benefit; the treatment/procedure must not be performed since it does not help and may be harmful for the patient&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The request for laboratory tests, electrocardiogram (ECG) and radiography (X-ray) of the chest in the preoperative evaluation of patients scheduled for surgical procedures is a common and routine clinical practice. This practice has been adopted since the 1960s and was recommended for all surgical patients regardless of age, type of procedure, and surgical size, even in asymptomatic healthy patients. However, this practice is associated with a high economic cost for the health system. From the 1990s, after reviews conducted by various medical associations on this issue, the rational use of diagnostic tests has been advocated to reduce costs, since there is no evidence that routine tests performed prior the surgery are related to reduction or are predictive of perioperative complications.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The definitions for levels of evidence (A-C) and classes of recommendation (I-III) are provided at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See the original guideline document for details on performing patient history and physical examination.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Electrocardiogram (ECG)&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations for requesting an ECG:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation I, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients with a history and/or abnormalities on physical examination suggestive of cardiovascular disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with a recent episode of ischemic chest pain or considered to be at high risk after algorithmic assessment or according to the assistant physician &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patients with diabetes mellitus &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Obese patients &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;All patients older than 40 years &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation III, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Routinely request an ECG for asymptomatic individuals who will be submitted to low-risk surgeries. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Chest X-ray&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations for requesting a chest x-ray:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation I, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients with a history or diagnostic tests suggestive of cardiorespiratory diseases &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Patients older than 40 years &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Medium to major surgeries, mainly intra-thoracic and intra-abdominal surgeries &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation III, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Routine in asymptomatic individuals &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Laboratory Tests&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations for requesting laboratory tests:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Full Blood Count&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation I, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;History of anemia or other hematologic diseases or liver diseases &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;When anemia is suspected during physical examination or when chronic diseases associated with anemia are present &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Moderate/high-risk surgeries if a need for transfusion is anticipated &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All patients older than 40 years &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation III, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Routine in asymptomatic individuals &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Hemostasis/Coagulation Tests&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation I, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Patients on anticoagulation therapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients with liver failure &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients with coagulation disorders (history of bleeding) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients who will be submitted to intermediate or high-risk surgeries &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation III, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Routine in asymptomatic individuals &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot; start=&quot;3&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Determination of Serum Creatinine&lt;/strong&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation I, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Patients with kidney disease, diabetes mellitus, hypertension, liver failure, or heart failure, and whose serum creatinine has not been determined in the last 12 months &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Patients who will be submitted to intermediate or high-risk surgeries &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;All patients older than 40 years &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Degree of Recommendation III, Level of Evidence C&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Routine in asymptomatic individuals &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: upper-alpha;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evidence in several populations from multiple randomized clinical trials or meta-analyses &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence in a limited group of populations from single randomized clinical trial or non-randomized clinical studies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Evidence in very limited group of populations from consensus and experts' opinions, case reports and series &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree/Class of Recommendation - Reflecting the Size of Treatment Effect&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation I&lt;/strong&gt; - Benefit &amp;gt;&amp;gt;&amp;gt; Risk; the treatment/procedure must be indicated/administered&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIa&lt;/strong&gt; - Benefit &amp;gt;&amp;gt; Risk; the choice for the treatment/procedure may help the patient&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation IIb&lt;/strong&gt; - Benefit &amp;gt; Risk; is not defined if the treatment/procedure can help the patient&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Degree of Recommendation III&lt;/strong&gt; - Risk &amp;gt; Benefit; the treatment/procedure must not be performed since it does not help and may be harmful for the patient&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The original guideline document contains a flowchart for perioperative evaluation.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Appropriate general assessment of patients for perioperative evaluation, which may lead to reduced perioperative complications, morbidity, and mortality&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Data or scientific evidence are not always available to allow all the different situations to be analyzed. As customary in medical practice, minute analysis of the patient and problem and the common sense of the team must prevail. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The surgical intervention does not finish when the patient is bandaged or leaves the operating room. The concept of the word perioperative includes the need for a postoperative surveillance whose intensity is determined by the individual level of risk of the patient. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Clinical Algorithm" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Safety" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gualandro DM, Yu PC, Calderaro D, Marques AC, Pinho C, Caramelli B, et al. General assessment. In: II guidelines of perioperative evaluation. Arq Bras Cardiol. 2011;96(3 Suppl 1):4-7. [379 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2007 (revised 2011)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Brazilian Society of Cardiology - Medical Specialty Society" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Brazilian Society of Cardiology&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Writing Committee Members&lt;/em&gt;: Danielle Menosi Gualandro, Pai Ching Yu, Daniela Calderaro, Bruno Caramelli&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Task Force Members&lt;/em&gt;: Alina Coutinho Rodrigues Feitosa, Andr&amp;eacute; Coelho Marques, Bruno Caramelli, Beatriz Ayub, Carisi A. Polanczyk, Carlos Jardim, Carolina L. Zilli Vieira, Claudio Pinho, Daniela Calderaro, Danielle Menosi Gualandro, Denise Iezzi, Dimas T. Ikeoka, Dirk Schreen, Elbio Antonio D'Amico, Elcio Pfeferman, Emerson Quintino de Lima, Emmanuel de A. Burdmann, Enrique Pachon, Fabio Santana Machado, Filomena Regina Barbosa Gomes Galas, Fl&amp;aacute;vio Jota de Paula, Francine Corr&amp;ecirc;a de Carvalho, Gilson Soares Feitosa-Filho, Gustavo Faibischew Prado, Heno F. Lopes, Jos&amp;eacute; Jaime Galv&amp;atilde;o de Lima, Julio Flavio Meirelles Marchini, Luciana S. Fornari, Luciano F. Drager, Luciano Janussi Vacanti, Ludhmila Abrah&amp;atilde;o Hajjar, Luis Eduardo P. Rohde, Lu&amp;iacute;s Henrique Gowdak, Luiz Francisco Cardoso, Marcelo Luiz Campos Vieira, Maristela C. Monachini, Milena Macatr&amp;atilde;o, Pai Ching Yu, Paula Ribeiro Villa&amp;ccedil;a, Pedro Silvio Farsky, Renato Delascio Lopes, Renato Scotti Bagnatori, Roberto Henrique Heinisch, Sandra F. Menosi Gualandro, Tarso Augusto Duenhas Accorsi, Walkiria Samuel &amp;Aacute;vila, Wilson Mathias Jr.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;See the original guideline document for mandatory conflict of interest declaration.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Committee on Perioperative Evaluation (CAPO), Brazilian Society of Cardiology. General approach to the patient. In: I guidelines for perioperative evaluation. Arq Bras Cardiol 2007;89(6):e175-86.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://publicacoes.cardiol.br/consenso/2011/II_diretriz_perioperatoria-ingles.pdf&quot; title=&quot;Arquivos Brasileiros de Cardiologia Web site&quot;&gt;Arquivos Brasileiros de Cardiologia Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on June 2, 2008. The information was verified by the guideline developer on July 2, 2008. This summary was updated by ECRI Institute on December 26, 2008 following the FDA advisory on Innohep (tinzaparin). This summary was updated by ECRI Institute on June 15, 2009 following the FDA advisory on Propylthiouracil (PTU). This summary was updated by ECRI Institute on May 27, 2010 following the revised FDA advisory on Propylthiouracil (PTU). This summary was updated by ECRI Institute on July 27, 2010 following the FDA drug safety communication on Heparin. This NGC summary was updated by ECRI Institute on November 16, 2011. The updated information was verified by the guideline developer on December 27, 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. For reproduction of these guidelines, please contact Bruno Caramelli, Comiss&amp;atilde;o de Avaliac&amp;atilde;o Perioperat&amp;oacute;ria da Brasileira de Cardiologia &amp;#8211; CAPO, Alameda Santos, 705 - 11&amp;deg; andar, S&amp;atilde;o Paulo SP, Brazil CEP: 01419-001.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
